01 1BrightGene Bio-Medical Technology Co.,Ltd
01 12-AMINO-1,9-DIHYDRO-9-[(1S,3R,4S)-4-(BENZYLOXY)-3-(BENZYLOXYMETHYL)-2-METHYLENE CYCLOPENTYL]-6H-PURINE-6-ONE(ET1)
01 1China
01 1Active
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26257
Submission : 2012-08-12
Status : Active
Type : II
20
Brightgene Bio-medical Technology Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is 2-AMINO-1,9-DIHYDRO-9-[(1S,3R,4S)-4-(BENZYLOXY)-3-(BENZYLOXYMETHYL)-2-METHYLENE CYCLOPENTYL]-6H-PURINE-6-ONE(ET1), with a corresponding US DMF Number 26257.
Remarkably, this DMF maintains an Active status since its submission on August 12, 2012, highlighting commitment to regulatory compliance.
